Vertex provides pipeline and business updates in advance of upcoming investor meetings

Boston--(business wire)--vertex pharmaceuticals incorporated (nasdaq: vrtx) today announced multiple program updates ahead of upcoming investor meetings in january, including the company's scheduled webcast from the 42nd annual j.p. morgan healthcare conference on monday, january 8, 2024 at 11:15 a.m. et/8:15 a.m. pt. “2023 was marked by continued strong performance in the cystic fibrosis business and acceleration of our development stage pipeline, propelling the company into 2024 with tremendo.
VRTX Ratings Summary
VRTX Quant Ranking